How embryonic cells develop specialized genetic structures in fruit flies
Embryonic Emergence of Heterochromatin and Nuclear Supervision of Mitochondrial Genetics
This study looks at how tiny cells in fruit flies change and develop special genetic structures that help organize their DNA, which could teach us more about how genes work during early growth.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10838464 on NIH RePORTER |
What this research studies
This research investigates the processes that control how embryonic cells in fruit flies differentiate and develop specialized genetic structures known as heterochromatin. By examining the timing and mechanisms involved in the formation of these structures, the study aims to uncover how genetic information is organized and regulated during early development. The researchers will utilize advanced in vivo techniques to explore the roles of specific proteins and sequences in this process, providing insights into the fundamental aspects of genetics and cell biology.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals interested in genetic disorders or developmental biology, particularly those with a focus on cancer genetics.
Not a fit: Patients with conditions unrelated to genetic regulation or developmental processes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of genetic regulation and its implications for developmental biology and cancer.
How similar studies have performed: While this research explores novel aspects of genetic regulation, similar studies have shown success in understanding chromatin dynamics and their implications in various biological processes.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: O'farrell, Patrick H — University of California, San Francisco
- Study coordinator: O'farrell, Patrick H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.